EGC is leading a collaborative national effort to raise awareness of a new tax law that requires capitalization of Research & Experimentation (R&E) expenses and detrimentally impacts companies conducting critical scientific work. Our letter to Congress has been signed by 501 companies and individuals from 48 states and DC, and is available here. We encourage scientific companies impacted by this law to reach out to your local representatives, and for SBIR/STTR companies to also reach out to the SBA at technology@sba.gov, to help spread awareness of the impact on your company. Full press release is available here.
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.
Related Posts
January 16, 2025
2025 Winter Webinar Series
January 7, 2025
January 2025 Newsletter
In our first newsletter of 2025, we highlight our clients' success in securing over $320 million in non-dilutive funding. We feature our 2024…
December 3, 2024
December 2024 Newsletter
In this final newsletter of 2024, we provide year-end financial tips to set you up for success in the year ahead and showcase exciting new SBIR/STTR…